Clinical Professor of Pediatrics, UC Irvine
Pediatric Infectious Disease
Dr. Antonio C. Arrieta, MD
|
|
Give Review
Antonio Arrieta is an expert in the field of Pediatric Infectious Disease. He has 5 awards "Top Doctors:LA Area", "Top Doctors:San Diego Area", "Top Doctors:Southern California", "Top MD" and "Super Doctor". Antonio C. Arrieta has written publications. He has 60 publications published with PubMed. The lastest publication is: 'Association of insulin-dependent diabetes mellitus and celiac disease: a study based on serologic markers.'
Publications
- Pharmacokinetics, Safety and Tolerability of Single Oral or Intravenous Administration of 200 mg Tedizolid Phosphate in Adolescents.
- Pharmacokinetic and safety profiles of repeated-dose prophylactic micafungin in children and adolescents undergoing hematopoietic stem cell transplantation.
- Population Pharmacokinetics of Micafungin and its Metabolites M1 and M5 in Children and Adolescents: Towards Further Certainty in Dosing.
- Intestinal fatty-acid binding protein and metronidazole response in premature infants.
- Candida Speciation, Antifungal Treatment, and Adverse Events in Pediatric Invasive Candidiasis: Results from 441 Infections in a Prospective, Multi-National Study.
- Effect of fluconazole prophylaxis on candidiasis and mortality in premature infants: a randomized clinical trial.
- Changes in the incidence of candidiasis in neonatal intensive care units.
- Safety and Pharmacokinetic Profiles of Repeated-Dose Micafungin in Children and Adolescents Treated for Invasive Candidiasis.
- Safety and effectiveness of meropenem in infants with suspected or complicated intra-abdominal infections.
- Clinical and laboratory features of pertussis in infants at the onset of a California epidemic.
- Safety of Micafungin in Pediatric Clinical Trials.
- Pharmacokinetics, safety, and tolerability of voriconazole in immunocompromised children.
- Listeria meningitis after infliximab treatment of ulcerative colitis.
- Once-weekly liposomal amphotericin B as Candida prophylaxis in very low birth weight premature infants: a prospective, randomized, open-label, placebo-controlled pilot...
- The impact of the central venous catheter on the diagnosis of infectious endocarditis using Duke criteria in children with Staphylococcus aureus bacteremia.
- Ertapenem or ticarcillin/clavulanate for the treatment of intra-abdominal infections or acute pelvic infections in pediatric patients.
- Risk factors for mortality resulting from bloodstream infections in a pediatric intensive care unit.
- Pharmacokinetics and safety of intravenous voriconazole in children after single- or multiple-dose administration.
- Randomized, blinded trial of weekend vs daily prednisone in Duchenne muscular dystrophy.
- Association of insulin-dependent diabetes mellitus and celiac disease: a study based on serologic markers.
- Oral maribavir for treatment of refractory or resistant cytomegalovirus infections in transplant recipients.
- Antibodies to human tissue transglutaminase for the diagnosis of celiac disease.
- Antibodies to gliadin, endomysium, and tissue transglutaminase for the diagnosis of celiac disease.
- In vitro activity of teicoplanin compared with vancomycin against methicillin-resistant Staphylococcus aureus derived from cystic fibrosis sputum.
- Coxsackie B2 meningitis with unusually high white blood cell count in cerebrospinal fluid.
- Down's syndrome and celiac disease.
- Use of serological markers as a screening test in family members of patients with celiac disease.
- Vitamin A levels in children with measles in Long Beach, California.
- Invasive group A streptococcal infections in children with varicella in Southern California.
- In-vitro activity of cefprozil (BMY 28100) and loracarbef (LY 163892) against pathogens obtained from middle ear fluid.
- Safety and pharmacokinetics of repeat-dose micafungin in young infants.
- Of bugs and drugs. A guide through the labyrinth of antimicrobial therapy for respiratory tract infections.
- Empiric use of cefepime in the treatment of lower respiratory tract infections in children.
- Use of meropenem in the treatment of serious infections in children: review of the current literature.
- Convalescent phase outpatient parenteral antiinfective therapy for children with complicated appendicitis.
- Commonly used antibacterial and antifungal agents for hospitalised paediatric patients: implications for therapy with an emphasis on clinical pharmacokinetics.
- Empiric use of cefepime in the treatment of serious urinary tract infections in children.
- A randomized, double-blind comparative trial evaluating the safety of liposomal amphotericin B versus amphotericin B lipid complex in the empirical treatment of febril...
- Comparative study of the safety and efficacy of clarithromycin and amoxicillin-clavulanate in the treatment of acute otitis media in children.
- Cytokine profiles of pediatric patients treated with antibiotics for pyelonephritis: potential therapeutic impact.
- Micafungin in pediatrics: when one size does not fit all.
- Population pharmacokinetics of micafungin in neonates and young infants.
- Population pharmacokinetics of meropenem in plasma and cerebrospinal fluid of infants with suspected or complicated intra-abdominal infections.
- Comparison of pharmacokinetics and safety of voriconazole intravenous-to-oral switch in immunocompromised children and healthy adults.
- Population pharmacokinetics of micafungin in pediatric patients and implications for antifungal dosing.
- Clinical research in the lay press: irresponsible journalism raises a huge dose of doubt.
- Safety, tolerability, and pharmacokinetics of Micafungin (FK463) in febrile neutropenic pediatric patients.
- Temporal trends in early clinical manifestations of perinatal HIV infection in a population-based cohort.
- Pharmacokinetics of an elevated dosage of micafungin in premature neonates.
- Chlamydophila pneumoniae myopericarditis in a child.
- Micafungin versus liposomal amphotericin B for pediatric patients with invasive candidiasis: substudy of a randomized double-blind trial.
- Severe lactic acidosis in association with reverse transcriptase inhibitors with potential response to L-carnitine in a pediatric HIV-positive patient.
- Management of recurrent and persistent acute otitis media: new options with familiar antibiotics.
- Neonate with chronic meningitis and hydrocephalus.
- High-dose azithromycin versus high-dose amoxicillin-clavulanate for treatment of children with recurrent or persistent acute otitis media.
- Efficacy of single-dose azithromycin in treatment of acute otitis media in children after a baseline tympanocentesis.
- Systemic inflammatory responses in children with acute otitis media due to Streptococcus pneumoniae and the impact of treatment with clarithromycin.
- Quinolone treatment for pediatric bacterial meningitis: a comparative study of trovafloxacin and ceftriaxone with or without vancomycin.
- Management of meningococcemia.
Schools
Universidad Peruana Cayetano Heredia Facultad De Medicina Alberto Hurtado
University Peruana Cayetano Heredia
Siu School Med Affil Hosps
Uci
Doctors Specialties
- Pediatric Infectious Disease Medicine
- Pediatric Infectious Disease
Accepted Insurances
Awards
- Top Doctors:LA Area
- Top Doctors:San Diego Area
- Top Doctors:Southern California
- Top MD
- Super Doctor
Education
-
Southern Illinois University -
Cayetano Heredia University
Hospital
-
UC Irvine Medical Center -
Children's Hospital of Orange County
Helpful Reviews
Similar Doctors
|
|
Dr. Negar Ashouri, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Behnoosh Afghani, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Delma J. Nieves, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Harris R. Stutman, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Felice C. Adler-Shohet, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Roopa Viraraghavan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nancy D. Dodd, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jasjit Singh, MD
This Doctor is OpenDoctor Recommended.
|